Suppr超能文献

胃轻瘫症状患者的便秘:症状和胃肠传输分析。

Constipation in Patients With Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal Transit.

机构信息

Temple University, Philadelphia, Pennsylvania.

Johns Hopkins University, Baltimore, Maryland.

出版信息

Clin Gastroenterol Hepatol. 2022 Mar;20(3):546-558.e5. doi: 10.1016/j.cgh.2020.10.045. Epub 2020 Oct 28.

Abstract

BACKGROUND & AIMS: Constipation can be an important symptom in some patients with gastroparesis. The aims were to: 1) Determine prevalence of constipation and delayed colonic transit in patients with symptoms of gastroparesis; 2) Correlate severity of constipation to severity of symptoms of gastroparesis; and 3) Relate severity of constipation to GI transit delays assessed by gastric emptying scintigraphy (GES) and wireless motility capsule (WMC).

METHODS

Patients with symptoms of gastroparesis underwent gastric emptying scintigraphy (GES), wireless motility capsule (WMC) assessing gastric emptying, small bowel transit, and colonic transit, and questionnaires assessing symptoms using a modified Patient Assessment of Upper GI Symptoms [PAGI-SYM] and Rome III functional GI disorder questionnaire.

RESULTS

Of 338 patients with symptoms of gastroparesis, 242 (71.5%) had delayed gastric emptying by scintigraphy; 298 (88.2%) also met criteria for functional dyspepsia. Severity of constipation was severe/very severe in 34% patients, moderate in 24%, and none/very mild/mild in 42%. Increasing severity of constipation was associated with increasing symptoms of gastroparesis and presence of irritable bowel syndrome (IBS). Severity of constipation was not associated with gastric retention on GES or WMC. Delayed colonic transit was present in 108 patients (32% of patients). Increasing severity of constipation was associated with increasing small bowel transit time, colonic transit time, and whole gut transit time.

CONCLUSIONS

Severe/very severe constipation and delayed colon transit occurs in a third of patients with symptoms of gastroparesis. The severity of constipation is associated with severity of gastroparesis symptoms, presence of IBS, small bowel and colon transit delay, but not delay in gastric emptying. ClinicalTrials.gov Identifier: NCT01696747.

摘要

背景与目的

便秘可能是一些胃轻瘫患者的重要症状。目的是:1)确定有胃轻瘫症状的患者便秘和结肠传输延迟的患病率;2)将便秘的严重程度与胃轻瘫症状的严重程度相关联;3)通过胃排空闪烁扫描(GES)和无线动力胶囊(WMC)评估胃排空、小肠传输和结肠传输来评估便秘的严重程度与 GI 传输延迟的关系。

方法

有胃轻瘫症状的患者接受胃排空闪烁扫描(GES)、无线动力胶囊(WMC)评估胃排空、小肠传输和结肠传输,以及使用改良的上胃肠道症状患者评估[PAGI-SYM]和罗马 III 功能性胃肠道障碍问卷评估症状的问卷。

结果

在 338 名有胃轻瘫症状的患者中,242 名(71.5%)通过闪烁扫描显示胃排空延迟;298 名(88.2%)也符合功能性消化不良的标准。34%的患者便秘严重/非常严重,24%的患者中度便秘,42%的患者无便秘/轻度便秘/轻度便秘。便秘的严重程度与胃轻瘫症状的严重程度以及存在肠易激综合征(IBS)相关。便秘的严重程度与 GES 或 WMC 上的胃潴留无关。108 名患者(32%的患者)存在结肠传输延迟。便秘严重程度与小肠传输时间、结肠传输时间和全肠传输时间增加相关。

结论

有胃轻瘫症状的患者中,有三分之一的患者存在严重/非常严重的便秘和结肠传输延迟。便秘的严重程度与胃轻瘫症状的严重程度、IBS 的存在、小肠和结肠传输延迟有关,但与胃排空延迟无关。临床试验.gov 标识符:NCT01696747。

相似文献

1
Constipation in Patients With Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal Transit.
Clin Gastroenterol Hepatol. 2022 Mar;20(3):546-558.e5. doi: 10.1016/j.cgh.2020.10.045. Epub 2020 Oct 28.
2
Impact of Constipation Therapies on Severity of Gastroparesis and Constipation Symptoms in Relation to Gastric and Colonic Transit.
Neurogastroenterol Motil. 2025 Jun;37(6):e70013. doi: 10.1111/nmo.70013. Epub 2025 Mar 3.
3
Validation of Diagnostic and Performance Characteristics of the Wireless Motility Capsule in Patients With Suspected Gastroparesis.
Clin Gastroenterol Hepatol. 2019 Aug;17(9):1770-1779.e2. doi: 10.1016/j.cgh.2018.11.063. Epub 2018 Dec 14.
6
The Assessment of Gastrointestinal Transit by the Atmo Capsule: A Comparison With the SmartPill Capsule.
Clin Gastroenterol Hepatol. 2025 Aug;23(9):1633-1641.e8. doi: 10.1016/j.cgh.2024.12.013. Epub 2025 Jan 30.
7
Baseline Predictors of Longitudinal Changes in Symptom Severity and Quality of Life in Patients With Suspected Gastroparesis.
Clin Gastroenterol Hepatol. 2022 Mar;20(3):e407-e428. doi: 10.1016/j.cgh.2020.09.032. Epub 2020 Sep 21.
8
Relating gastric scintigraphy and symptoms to motility capsule transit and pressure findings in suspected gastroparesis.
Neurogastroenterol Motil. 2018 Feb;30(2). doi: 10.1111/nmo.13196. Epub 2017 Sep 5.
9
Influence of Gastric Emptying and Gut Transit Testing on Clinical Management Decisions in Suspected Gastroparesis.
Clin Transl Gastroenterol. 2019 Oct;10(10):e00084. doi: 10.14309/ctg.0000000000000084.
10
Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
Cochrane Database Syst Rev. 2007 Oct 17(4):CD003960. doi: 10.1002/14651858.CD003960.pub3.

引用本文的文献

3
Functional dyspepsia and gastroparesis: are they distinct disorders, a spectrum of diseases or one disease?
eGastroenterology. 2025 Jan 23;3(1):e100119. doi: 10.1136/egastro-2024-100119. eCollection 2025 Jan.
4
Diabetic gastroenteropathy: a pan-alimentary complication.
Diabetologia. 2025 May;68(5):905-919. doi: 10.1007/s00125-025-06365-y. Epub 2025 Feb 11.
6
Therapeutic approaches targeting aging and cellular senescence in Huntington's disease.
CNS Neurosci Ther. 2024 Oct;30(10):e70053. doi: 10.1111/cns.70053.
8
Epidemiology of Disorders of the Gut-Brain Interaction: An Appraisal of the Rome IV Criteria and Beyond.
Gut Liver. 2024 Jul 15;18(4):578-592. doi: 10.5009/gnl230396. Epub 2024 Apr 29.

本文引用的文献

1
Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study.
Am J Gastroenterol. 2019 Aug;114(8):1265-1274. doi: 10.14309/ajg.0000000000000304.
2
Use of prucalopride in adults with chronic idiopathic constipation.
Expert Rev Clin Pharmacol. 2019 Jul;12(7):579-589. doi: 10.1080/17512433.2019.1620104. Epub 2019 May 23.
3
High Prevalence of Slow Transit Constipation in Patients With Gastroparesis.
J Neurogastroenterol Motil. 2019 Apr 30;25(2):267-275. doi: 10.5056/jnm18206.
4
Exploring the Diabetic Gastroparesis Patient Experience: Patient Exit Interviews.
Adv Ther. 2017 Dec;34(12):2680-2692. doi: 10.1007/s12325-017-0632-6. Epub 2017 Oct 27.
5
The PAC-SYM questionnaire for chronic constipation: defining the minimal important difference.
Aliment Pharmacol Ther. 2017 Dec;46(11-12):1103-1111. doi: 10.1111/apt.14349. Epub 2017 Oct 6.
6
Relating gastric scintigraphy and symptoms to motility capsule transit and pressure findings in suspected gastroparesis.
Neurogastroenterol Motil. 2018 Feb;30(2). doi: 10.1111/nmo.13196. Epub 2017 Sep 5.
8
Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying.
Clin Gastroenterol Hepatol. 2011 Jul;9(7):567-76.e1-4. doi: 10.1016/j.cgh.2011.03.003. Epub 2011 Mar 11.
9
Diagnostic utility of wireless motility capsule in gastrointestinal dysmotility.
J Clin Gastroenterol. 2011 Sep;45(8):684-90. doi: 10.1097/MCG.0b013e3181ff0122.
10
The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology.
Aliment Pharmacol Ther. 2010 Jan 15;31(2):313-22. doi: 10.1111/j.1365-2036.2009.04162.x. Epub 2009 Oct 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验